An increase in a quarterly dividend payment is something all income investors love to hear about. Two stocks that have been raising their payouts for decades are AbbVie (NYSE: ABBV) and ExxonMobil (NYSE: XOM). Let's find out a bit more about these two dividend stocks.
Many investors dream of building a portfolio that delivers significant passive income. Let's delve into a few arguments in favor of loading up on passive income stocks right now and a few in favor of holding off. One big argument in favor of buying passive income stocks right now is investors will be able to lock in more income for each invested dollar than before.
AbbVie (NYSE: ABBV) announced today the availability of the XEN® 63 Gel Implant, a surgical implant designed to lower high eye pressure in open angle glaucoma sufferers, where previous medical treatment options have failed.1 The XEN 63 Gel Implant is an additional option for surgeons, clinically proven to reduce intraocular pressure (IOP) in patients with primary open angle glaucoma.3